118 results match your criteria: "centre hospitalier universitaire Pontchaillou[Affiliation]"

Epistaxis greatly affects patients with hereditary hemorrhagic telangiectasia (HHT). Although few systemic treatment exist, nintedanib, is a good candidate thanks to its anti-angiogenic activity. Our main objective was to evaluate the efficacy of oral nintedanib on epistaxis duration in HHT patients with moderate to severe epistaxis.

View Article and Find Full Text PDF

Context: Poor medication management can lead to adverse outcomes for transplant patients, including acute rejection and graft loss. In recent years, mobile applications have been proposed as innovative tools to improve patient treatment management.

Objective: This review aimed to systematically evaluate the available research evidence on the relationship between mobile applications and treatment management in transplant patients.

View Article and Find Full Text PDF

Background: Patients with acute basilar artery occlusion (BAO) and low-to-moderate symptoms (National Institutes of Health Stroke Scale [NIHSS] < 10) are poorly represented in thrombectomy trials. Our objective is to compare thrombectomy and best medical management (BMT) in this population.

Methods: We compared data of all consecutive patients presenting with an initial NIHSS < 10 and acute symptomatic BAO included in two registries.

View Article and Find Full Text PDF

Purpose: The occurrence of genitourinary (GU) toxicity is a common adverse event observed after external beam radiation therapy (EBRT) for prostate cancer (PCa). Recent findings suggest that the dose delivered to specific urinary organs at risk (OARs) such as the ureters, bladder trigone, and urethra is involved in the development of GU toxicity.

Methods And Materials: A multidisciplinary task force including 3 radiation oncologists, a uroradiologist, and a urologist was created in 2022.

View Article and Find Full Text PDF
Article Synopsis
  • * MRS significantly lowered the curative resection rate (41.6%) compared to lesions without MRS (81.3%) and increased rates of perforation and need for secondary surgeries.
  • * The study suggests that if MRS is detected, ESD should be halted for colon lesions due to poor outcomes but can continue for rectal lesions due to higher risks associated with alternative treatments.
View Article and Find Full Text PDF

Legionnaires Disease in Solid Organ Transplant Recipients: A Decade-Long Nationwide Study in France.

Chest

March 2024

Service de Maladies Infectieuses et Tropicales, Hôpital Universitaire, Sorbonne Université, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France. Electronic address:

Article Synopsis
  • - Legionnaires' disease (LD) is a serious infection particularly affecting solid organ transplant recipients, though details about its impact on this group have not been well documented.
  • - A 10-year study in France identified 101 patients with LD among transplant recipients, finding that severe cases were linked to factors like negative urinary antigen tests and respiratory symptoms.
  • - Key imaging results showed significant lung involvement, and the study reported a 30-day mortality rate of 8% and a 12-month mortality rate of 20% among these patients.
View Article and Find Full Text PDF

Introduction: The knowledge of dabigatran levels is helpful for decision-making in specific situations such as urgent surgery or when the question of reversal arises (uncontrolled bleeding, eligibility for thrombolysis). However, a limited number of observational studies are available regarding comparisons between quantification methods. The objective of the study was to compare dabigatran plasma levels using three assays including the reference method (high-performance liquid chromatography coupled with mass spectrometry), focusing on the agreement around the 30-50 ng/mL clinically relevant thresholds.

View Article and Find Full Text PDF

BDNF as potential biomarker of epilepsy severity and psychiatric comorbidity: pitfalls in the clinical population.

Epilepsy Res

September 2023

APHM, Timone Hospital, Epileptology and Cerebral Rhythmology, Marseille, France; Aix Marseille Univ, INSERM, INS, Inst Neurosci Syst, Marseille, France.

Article Synopsis
  • The study investigated the role of brain-derived neurotrophic factor (BDNF) in epilepsy, specifically looking at its potential as a biomarker for epilepsy severity and related psychiatric conditions.
  • It analyzed serum BDNF levels in epilepsy patients from four centers in France, while documenting various clinical characteristics and conducting psychiatric screenings.
  • The results showed no significant correlation between serum BDNF levels and epilepsy features or depression, but found that the presence of anti-seizure medications (ASM) was linked to increased BDNF, especially with valproate and perampanel.
View Article and Find Full Text PDF

Introduction: Extraintestinal manifestations (EIMs) of inflammatory bowel disease (IBD) are challenging clinical situation. No prospective study assessed remission risk factors of EIMs. The aim of this study was to prospectively investigate the epidemiology, risk factors of EIM occurrence, and EIM remission in a large IBD cohort.

View Article and Find Full Text PDF

Background: Lithium is well recognized as the first-line maintenance treatment for bipolar disorder (BD). However, besides therapeutic benefits attributed to lithium therapy, the associated side effects including endocrinological and renal disorders constitute important parameters in prescribing patterns and patient adherence. The objectives of this study is to (i) determine whether long-term lithium therapy is associated with a decrease in renal function, hyperparathyroidism and hypercalcemia and (ii) identify risk factors for lithium-induced chronic kidney disease (CKD).

View Article and Find Full Text PDF

Psoriasis is a chronic inflammatory disease affecting about 100 million people worldwide. Around 80% of patients can be treated with topical agents, most commonly corticosteroids and vitamin D analogues. A topical foam formulation of calcipotriol (50 μg/g) and betamethasone dipropionate (0.

View Article and Find Full Text PDF

Background: Dupilumab is the first biotherapy available for the treatment of moderate-to-severe childhood atopic dermatitis (AD).

Objective: The aim of this study was to evaluate the effectiveness and safety of dupilumab in daily practice.

Methods: Patients aged 6-11, who had received a first dose of dupilumab, were included in this multicentre retrospective cohort study.

View Article and Find Full Text PDF

Cryptococcal Meningitis in Kidney Transplant Recipients: A Two-Decade Cohort Study in France.

Pathogens

June 2022

Service de Soins Intensifs Néphrologiques et Rein Aigu, French Intensive Renal Network, Hôpital Tenon, 75020 Paris, France.

Cryptococcosis is the third most common cause of invasive fungal infection in solid organ transplant recipients and cryptococcal meningitis (CM) its main clinical presentation. CM outcomes, as well as its clinical features and radiological characteristics, have not yet been considered on a large scale in the context of kidney transplantation (KT). We performed a nationwide retrospective study of adult patients diagnosed with cryptococcosis after KT between 2002 and 2020 across 30 clinical centers in France.

View Article and Find Full Text PDF
Article Synopsis
  • Biological therapies are effective for treating severe psoriasis in children under 12, but this age group is often not included in clinical trials.
  • The 'BiPe Jr' study analyzed data from 82 children in France and Italy who received biological treatments, showcasing significant improvement in psoriasis severity and treatment duration for drugs like adalimumab and ustekinumab.
  • Although 52 children stopped their treatments mostly due to ineffectiveness and remission, the study pointed out safety concerns with reports of serious adverse events, including severe infections.
View Article and Find Full Text PDF

Objective: Cryopyrin-associated periodic syndrome (CAPS) is a rare but treatable inherited autoinflammatory condition including familial cold autoinflammatory syndrome (FCAS), Muckle-Wells syndrome (MWS) and chronic infantile neurologic cutaneous articular syndrome (CINCA). Our objective was to describe the main features of CAPS AA amyloidosis (AA-CAPS) associated and the efficacy of IL-1 inhibitors in this indication.

Methods: Retrospective study in France associated with a systematic literature review.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to analyze the clinical practice and safety of switching biologics among pediatric psoriasis patients in the BiPe cohort, which included 134 patients.
  • Out of the patients, 29 switched biologics mainly due to loss of efficacy, with most transitions occurring from etanercept to adalimumab or ustekinumab.
  • The research found no significant differences in drug survival rates based on whether the biologics were used as first-line or second-line treatments, indicating a need for more data to guide switching in clinical practice.
View Article and Find Full Text PDF

Kidney function monitoring in inflammatory bowel disease: The MONITORED consensus.

Dig Liver Dis

March 2022

Department of Gastroenterology and Inserm NGERE U1256, University Hospital of Nancy, University of Lorraine, Vandoeuvre-lès-Nancy, France.

Background And Aims: Patients with inflammatory bowel diseases (IBD) are exposed to drug-related nephrotoxicity and kidney-related extra-intestinal manifestations (EIMs). Patients should be monitored but guidance is lacking in current international recommendations. The objective of the Kidney Function Monitoring in Inflammatory Bowel Disease (MONITORED) initiative was to achieve an expert consensus about monitoring kidney function in IBD.

View Article and Find Full Text PDF
Article Synopsis
  • Younger individuals, those with oligoclonal bands, and patients with specific brain and spinal cord lesions have a higher risk of developing multiple sclerosis (MS) from radiologically isolated syndrome (RIS) over a 10-year period.
  • A study aimed to assess the 2-year risk of MS symptoms in people with RIS and identify factors influencing this risk, as well as determine the necessary sample size for future clinical trials.
  • Out of 372 participants with RIS, 354 were analyzed, and 13.8% experienced a clinical event within 2 years, with a significant correlation to being younger than 37, indicating an estimated conversion risk of 19.2%.
View Article and Find Full Text PDF

Background And Purpose: In the settings of thrombectomy, the first-pass effect (FPE), defined by a complete recanalization after one pass with no rescue therapy, has been shown to be associated with an improved outcome. As this phenomenon has been predominantly described in anterior circulation strokes, we aimed to study the prevalence, outcomes, and predictors of FPE in patients with a basilar artery occlusion.

Methods: From a prospective multicentric registry, we collected the data of all consecutive basilar artery occlusion patients who underwent thrombectomy and compared the outcomes of patients who achieved FPE and those who did not.

View Article and Find Full Text PDF

Trimethoprim/sulfamethoxazole for nocardiosis in solid organ transplant recipients: Real-life data from a multicentre retrospective study.

Transpl Infect Dis

August 2021

Service de Microbiologie, Unité Mobile d'Infectiologie, AP-HP, Hôpital Européen Georges Pompidou, Paris, France.

Background: Little is known regarding the optimal management of nocardiosis among solid organ transplant (SOT) recipients. It is often suggested to avoid trimethoprim/sulfamethoxazole (TMP-SMX) monotherapy in heavily immunocompromised patients (such as SOT recipients) and/or in case of severe or disseminated nocardiosis. Our aim was to report our experience with TMP-SMX monotherapy in SOT recipients with nocardiosis.

View Article and Find Full Text PDF